Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Capital Expenditures (2016 - 2026)

Corcept Therapeutics (CORT) has disclosed Capital Expenditures for 15 consecutive years, with $201000.0 as the latest value for Q1 2026.

  • For Q1 2026, Capital Expenditures rose 93.27% year-over-year to $201000.0; the TTM value through Mar 2026 reached $308000.0, down 86.47%, while the annual FY2025 figure was $211000.0, 90.29% down from the prior year.
  • Capital Expenditures hit $201000.0 in Q1 2026 for Corcept Therapeutics, up from $50000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $1.6 million in Q3 2024 and bottomed at $12000.0 in Q1 2022.
  • Average Capital Expenditures over 5 years is $241230.8, with a median of $102000.0 recorded in 2023.
  • Year-over-year, Capital Expenditures tumbled 90.48% in 2022 and then skyrocketed 4318.92% in 2024.
  • Corcept Therapeutics' Capital Expenditures stood at $31000.0 in 2022, then increased by 19.35% to $37000.0 in 2023, then soared by 227.03% to $121000.0 in 2024, then crashed by 58.68% to $50000.0 in 2025, then surged by 302.0% to $201000.0 in 2026.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $201000.0, $50000.0, and $57000.0 for Q1 2026, Q4 2025, and Q2 2025 respectively.